Related Experiment Video
Updated: Jan 12, 2026

A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials
Published on: March 3, 2023
Analysis of vancomycin administration to patients with one kidney
Hitomi Motomura1, Masashi Uchida1, Shingo Yamazaki1
1Graduate School of Pharmaceutical Sciences, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba, 260-8675, Japan; Division of Pharmacy, Chiba University Hospital, Chiba, Japan.
Introduction:
When one kidney is lost, the other works to compensate. The renally excreted antibiotic vancomycin (VCM) requires therapeutic drug monitoring to avoid renal injury and ensure efficacy. However, no studies have clarified whether the dosing regimen for patients with two kidneys can be used in patients with one kidney. We investigated whether patients with one kidney are able to receive VCM with the same dosing regimen as patients with two kidneys.
Methods:
This retrospective case series included patients with one kidney who were treated with VCM at Chiba University Hospital. Changes in serum creatinine (Scr) values and VCM trough concentrations were assessed. To evaluate individual VCM pharmacokinetic (PK) parameters in patients with one kidney, we performed Bayesian estimation using two population PK models for Japanese patients with two kidneys.
Results:
Six patients with one kidney were included in this study. The median loading dose and maintenance dose were 20.6 mg/kg and 28.3 mg/kg/day, respectively. Scr showed little change from before to after VCM administration (before, median 0.93 [0.72-1.32] mg/dL; after, 0.85 [0.69-1.22] mg/dL), and no patients developed VCM-associated nephrotoxicity. The trough concentration of VCM remained within the effective blood range of 10-20 μg/mL in almost all patients. There was a significant and strong correlation between the observed and Bayesian-estimated VCM trough concentrations for both population PK models.
Conclusion:
Patients with one kidney may be able to receive VCM with the same dosing regimen as patients with two kidneys.
Insights
Patients with a single kidney can likely receive vancomycin (VCM) using the same dosing as those with two kidneys. This study found stable kidney function and effective VCM levels in patients with one kidney on standard VCM regimens.
Area of Science:
- Nephrology
- Pharmacology
- Infectious Diseases
Background:
- Compensatory hypertrophy occurs in the remaining kidney after unilateral nephrectomy.
- Vancomycin (VCM) is renally excreted and requires therapeutic drug monitoring to prevent nephrotoxicity and ensure efficacy.
- Dosing guidelines for vancomycin in patients with two kidneys have not been validated for those with a single kidney.
Purpose of the Study:
- To investigate the safety and efficacy of standard vancomycin dosing regimens in patients with a single functioning kidney.
- To determine if patients with one kidney can be treated with vancomycin using the same dosing strategy as patients with two kidneys.
Main Methods:
- Retrospective case series of six patients with one kidney treated with vancomycin at Chiba University Hospital.
- Assessment of serum creatinine (Scr) and vancomycin (VCM) trough concentrations.
- Bayesian estimation using two population pharmacokinetic (PK) models for Japanese patients with two kidneys to evaluate individual VCM PK parameters.
Main Results:
- Six patients with a single kidney received vancomycin with median loading and maintenance doses of 20.6 mg/kg and 28.3 mg/kg/day, respectively.
- Serum creatinine levels remained stable, with no instances of vancomycin-associated nephrotoxicity.
- Vancomycin trough concentrations consistently stayed within the therapeutic range of 10-20 μg/mL for most patients.
Conclusions:
- Patients with a single kidney may safely receive vancomycin with the same dosing regimen as patients with two kidneys.
- Standard vancomycin dosing appears effective and safe in the setting of unilateral renal agenesis or nephrectomy.
More Related Videos
10:31Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
Published on: May 2, 2025
11:28A Reference Broth Microdilution Method for Dalbavancin In Vitro Susceptibility Testing of Bacteria that Grow Aerobically
Published on: September 9, 2015
Related Concept Videos
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Estimation of k and VD of Aminoglycosides
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
Renal Drug Excretion: Tubular Secretion
Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance